Overview
Dr. Sharon Castellino is the director of the Leukemia/Lymphoma (LL) program for the Aflac Cancer and Blood Disorders Center and also serves as the co-leader of the LL biorepository and vice-chair of the Aflac Precision Medicine Program protocol.
Outcomes Research
Dr. Castellino’s overarching research is related to outcomes and late effects in Pediatric Leukemia and Lymphoma patients and survivors, with a focus on Hodgkin Lymphoma (HL).
She is the Scientific Chair for the Hodgkin Lymphoma Program in the Children’s Oncology Group (COG). She also has leadership within the COG guidelines task force on survivorship care, with expertise in understanding hepatic late effects in childhood cancer. As a clinical trialist she has led paradigm-changing trials for pediatric Hodgkin Lymphoma.
Her investigator-initiated research has been in retrospective data analyses of large datasets, with a focus on examining disparities in outcomes and improving outcomes for adolescents and young adults (AYA) with blood cancer.